geraniol and Disease Models, Animal

Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection

Topics: Animals; Anti-Bacterial Agents; Cattle; Disease Models, Animal; Drug Residues; Escherichia coli; Female; Mastitis, Bovine; Mice; Microbiota

Topics: Acetylcholinesterase; Animals; Corticosterone; Disease Models, Animal; Fluoxetine; Hippocampus; Hypothalamo-Hypophyseal System; Mice; Pituitary-Adrenal System; Stress Disorders, Post-Traumatic

Topics: Acyclic Monoterpenes; Animals; Anti-Inflammatory Agents; Cytokines; Disease Models, Animal; HEK293 Cells; Humans; Kv1.3 Potassium Channel; Male; Mice, Inbred BALB C; Potassium Channel Blockers; Psoriasis; T-Lymphocytes

Topics: Acyclic Monoterpenes; Aggrecans; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cells, Cultured; Chondrocytes; Collagen Type II; Cyclic AMP-Dependent Protein Kinases; Cyclooxygenase 2; Dinoprostone; Disease Models, Animal; Extracellular Matrix; Interleukin-1beta; Interleukin-6; Male; MAP Kinase Signaling System; Menisci, Tibial; Mice, Inbred C57BL; NF-kappa B p50 Subunit; Nitric Oxide; Nitric Oxide Synthase Type II; Osteoarthritis; Phosphatidylinositol 3-Kinases; Tumor Necrosis Factor-alpha

Topics: Acyclic Monoterpenes; Animals; Anticonvulsants; Brain Chemistry; Catalase; Cymbopogon; Disease Models, Animal; Flumazenil; Glutathione; Malondialdehyde; Medicine, Traditional; Neuroprotective Agents; Oils, Volatile; Oxidative Stress; Pentylenetetrazole; Plant Extracts; Plant Leaves; Receptors, GABA-A; Seizures; Zebrafish

Topics: Acyclic Monoterpenes; Animals; Anti-Bacterial Agents; Disease Models, Animal; Dysentery, Bacillary; Enzyme Inhibitors; Lepidoptera; Protein Disulfide-Isomerases; Shigella sonnei; Survival Analysis; Terpenes; Treatment Outcome

Topics: Acyclic Monoterpenes; Administration, Oral; Animal Structures; Animals; Anti-Bacterial Agents; Catheter-Related Infections; Catheterization, Central Venous; Catheters; Disease Models, Animal; Histocytochemistry; Jugular Veins; Rats; Staphylococcal Infections; Staphylococcus epidermidis; Terpenes

Topics: Acyclic Monoterpenes; Animals; Anti-Allergic Agents; Anti-Inflammatory Agents, Non-Steroidal; Calcimycin; Cell Line; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Histamine; Humans; Inflammation Mediators; Mice; Mice, Inbred BALB C; Molecular Structure; Ovalbumin; Rhinitis, Allergic; Structure-Activity Relationship; Terpenes; Tetradecanoylphorbol Acetate

Topics: Acyclic Monoterpenes; Animals; Anti-Inflammatory Agents; Antioxidants; Disease Models, Animal; Galactosamine; Interleukin-1beta; Lipopolysaccharides; Liver; Liver Failure, Acute; Male; Mice; Mice, Inbred C57BL; NF-kappa B; Oils, Volatile; Plant Oils; PPAR gamma; Protective Agents; Signal Transduction; Terpenes; Tumor Necrosis Factor-alpha

Topics: Acyclic Monoterpenes; Animals; Chemokines; Cytokines; Diphosphonates; Disease Models, Animal; Gene Expression Regulation; Humans; Mevalonate Kinase Deficiency; Mice; Species Specificity; Terpenes

Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Acyclic Monoterpenes; alpha-Synuclein; Animals; Corpus Striatum; Disease Models, Animal; Dopamine; Dopaminergic Neurons; Lewy Bodies; Male; Mice; Mice, Inbred C57BL; Monoamine Oxidase; MPTP Poisoning; Neuromuscular Diseases; Parkinson Disease, Secondary; Substantia Nigra; Terpenes

Topics: Acyclic Monoterpenes; Administration, Oral; Animals; Body Weight; Brain; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Disease Models, Animal; Hydrogen Peroxide; Hyperalgesia; Hypoglycemic Agents; Lipid Peroxidation; Male; Malondialdehyde; Oxidoreductases; Psychomotor Disorders; Rats; Rats, Wistar; Reactive Oxygen Species; Sciatic Nerve; Terpenes

Topics: Acrylamide; Acyclic Monoterpenes; Administration, Oral; Animals; Antioxidants; Behavior, Animal; Brain; Curcumin; Disease Models, Animal; Humans; Male; Mitochondria; Neuroprotective Agents; Neurotoxicity Syndromes; Oxidative Stress; Rats; Rats, Wistar; Sciatic Nerve; Terpenes

Topics: Acyclic Monoterpenes; Animals; Antioxidants; Atherosclerosis; Cricetinae; Diet, Atherogenic; Disease Models, Animal; Endothelium; Lipid Peroxidation; Lipid Peroxides; Lipids; Male; NF-E2-Related Factor 2; Nitric Oxide; Oxidation-Reduction; Oxidative Stress; Random Allocation; Terpenes

Topics: Acyclic Monoterpenes; Animals; Antidepressive Agents; Carrier Proteins; Caspase 1; Chronic Disease; Corticosterone; Depressive Disorder; Disease Models, Animal; Fluoxetine; Inflammasomes; Interleukin-1beta; Male; Mice, Inbred ICR; Neuroimmunomodulation; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Prefrontal Cortex; Stress, Psychological; Terpenes; Uncertainty

Topics: Acyclic Monoterpenes; Animals; Animals, Genetically Modified; Disease Models, Animal; Drosophila; Oxidative Stress; Parkinson Disease; Plant Extracts; Protective Agents; Terpenes

Topics: Action Potentials; Acyclic Monoterpenes; Administration, Oral; Analgesics; Animals; Behavior, Animal; Disease Models, Animal; Dose-Response Relationship, Drug; Electrophysiological Phenomena; In Vitro Techniques; Injections, Intraperitoneal; Kinetics; Male; Mice; Models, Neurological; Neural Conduction; Neuritis; Neurons; Sciatic Nerve; Synaptic Transmission; Terpenes

Topics: Acetylmuramyl-Alanyl-Isoglutamine; Acyclic Monoterpenes; Alendronate; Animals; Disease Models, Animal; Diterpenes; Farnesol; Inflammation; Male; Mevalonate Kinase Deficiency; Mice; Mice, Inbred BALB C; Terpenes